CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weissfeld, J. L.
Right arrow Articles by Schoen, R. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Weissfeld, J. L.
Right arrow Articles by Schoen, R. E.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 586-587, June 2003
© 2003 American Association for Cancer Research


Letters to the Editor


 

Reply

Joel L. Weissfeld and Robert E. Schoen

Department of Epidemology and Division of Gastroenterology and Hepatology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213-5582

Global tests of general association do not show statistically significant associations between sex-specific VAT quartile and IGF measures, dichotomized as sex-specific median cut-points. Scatter plots do not provide strong evidence for an inverse U-shaped association between IGF-I and VAT, in men (Fig. 1)Citation or women (Fig. 2)Citation . The elevated odds of high median IGF-I in women with second quartile VAT relative to women with first quartile VAT probably represents a chance occurrence related to the specific cut-points chosen to convert variables (e.g., IGF-I and VAT) measured on an interval scale into analytic variables measured on an ordinal scale.



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1. Association between IGF-I and VAT, in men (n = 267), with least square quadratic regression curve (F value = 0.28, 2 degrees of freedom; P = 0.76).

 


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 2. Association between IGF-I and VAT, in women (n = 165), with least square quadratic regression curve (F value = 0.59, 2 degrees of freedom; P = 0.56).

 

Footnotes

The abbreviations used are: VAT, visceral adipose tissue; IGF, insulin-like growth factor. Back

Received 2/28/03; accepted 3/19/03.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weissfeld, J. L.
Right arrow Articles by Schoen, R. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Weissfeld, J. L.
Right arrow Articles by Schoen, R. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation